Alerts will be sent to your verified email
Verify EmailAKUMS
Akums Drugs & Pharma
|
Shilpa Medicare
|
Acutaas Chemicals
|
|
---|---|---|---|
Operational Metrics
|
|||
Pharmaceutical Sector
|
|||
DMF Filingsby API
|
20.0 . | n/a | n/a |
R&D as a % of Total Sales
|
2.69 % | 2.69 % | n/a |
Financials
|
|||
5 yr Average ROE
|
-1.49 % | 5.0 % | 18.21 % |
5yr average Equity Multiplier
|
3.89 | 1.64 | 1.75 |
5yr Average Asset Turnover Ratio
|
1.2 | 0.39 | 0.82 |
5yr Avg Net Profit Margin
|
0.42 % | 7.72 % | 12.12 % |
Price to Book
|
3.66 | 3.57 | 6.84 |
P/E
|
52.46 | 108.19 | 56.45 |
5yr Avg Cash Conversion Cycle
|
54.08 Days | 76.54 Days | 58.6 Days |
Inventory Days
|
59.02 Days | 105.79 Days | 65.78 Days |
Days Receivable
|
73.33 Days | 113.53 Days | 111.06 Days |
Days Payable
|
80.99 Days | 120.58 Days | 142.05 Days |
5yr Average Interest Coverage Ratio
|
5.39 | 11.52 | 19.71 |
5yr Avg ROCE
|
6.35 % | 6.65 % | 22.58 % |
5yr Avg Operating Profit Margin
|
5.28 % | 17.76 % | 19.73 % |
5 yr average Debt to Equity
|
0.47 | 0.44 | 0.34 |
5yr CAGR Net Profit
|
n/a | -27.23 % | 9.26 % |
5yr Average Return on Assets
|
0.52 % | 3.1 % | 10.12 % |
Shareholdings
|
|||
Promoter Holding
|
75.26 % | 44.23 % | 35.96 % |
Share Pledged by Promoters
|
0.0 | 7.92 % | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | -5.78 % | -5.09 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.93 % | 3.04 % | 10.94 % |
Akums Drugs & Pharma
|
Shilpa Medicare
|
Acutaas Chemicals
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|
Asset Break-Up - Segment Wise
|